IL1B and major depressive disorder: Promisingly, the probiotic Bifidobacterium adolescentis has demonstrated therapeutic effects by reducing hippocampal pro-inflammatory cytokine levels (e.g., IL-1β, TNF-α) and ameliorating depression-like behaviors in chronically stressed mouse models (8), suggesting microbiota modulation might be a possible treatment strategy.